El-Gebaly, F., Abou-Saif, S., Elkadeem, M., Helmy, A., Abd-Elsalam, S., Yousef, M., . . . El-Demerdash, T. (2019). Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients. Current cancer drug targets, 19(11), 896. https://doi.org/10.2174/1568009619666190718141647
Chicago Style (17th ed.) CitationEl-Gebaly, Fatma, Sabry Abou-Saif, Mahmoud Elkadeem, Amal Helmy, Sherief Abd-Elsalam, Mohamed Yousef, Reham Abdelkader Elkhouly, Ibrahim Fathi Amer, and Taher El-Demerdash. "Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients." Current Cancer Drug Targets 19, no. 11 (2019): 896. https://doi.org/10.2174/1568009619666190718141647.
MLA (9th ed.) CitationEl-Gebaly, Fatma, et al. "Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients." Current Cancer Drug Targets, vol. 19, no. 11, 2019, p. 896, https://doi.org/10.2174/1568009619666190718141647.